Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Vistagen Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- −4 vs. Q4 2023
- Shares held
- 17.3M
- −296.5K (−1.7%) vs. Q4 2023
- Total value
- $90.8M
- +$839.3K (+0.9%) vs. Q4 2023
- New holders
- 7
- 12 more added
- Sold out
- 11
- 10 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $2.54M |
| Q1 2026 | 56 | $8.12M |
| Q4 2025 | 55 | $8.84M |
| Q3 2025 | 58 | $81.8M |
| Q2 2025 | 51 | $30.3M |
| Q1 2025 | 48 | $39.0M |
| Q4 2024 | 54 | $44.9M |
| Q3 2024 | 47 | $45.3M |
| Q2 2024 | 43 | $56.3M |
| Q1 2024 | 42 | $90.8M |
| Q4 2023 | 46 | $90.0M |
| Q3 2023 | 34 | $15.7M |
| Q2 2023 | 33 | $1.82M |
| Q1 2023 | 83 | $4.79M |
| Q4 2022 | 86 | $4.15M |
| Q3 2022 | 93 | $9.13M |
| Q2 2022 | 112 | $122.1M |
| Q1 2022 | 116 | $167.8M |
| Q4 2021 | 106 | $269.2M |
| Q3 2021 | 105 | $360.2M |
| Q2 2021 | 101 | $389.0M |
| Q1 2021 | 74 | $225.2M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 16 | $84 | 0.00% | 00.0% | Unchanged |
| Fairman Group, LLC | 29 | $153 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 80 | $422 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 81 | $437 | 0.00% | +81 | New |
| Wells Fargo & Company | 211 | $1.11K | 0.00% | +3+1.4% | Added |
| BFSG, LLC | 1,000 | $5.28K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 2,416 | $13.0K | 0.00% | −33−1.3% | Reduced |
| Tower Research Capital LLC (TRC) | 3,444 | $18.2K | 0.00% | −5,854−63.0% | Reduced |
| UBS Group AG | 4,736 | $25.0K | 0.00% | +4,619+3,947.9% | Added |
| GPS Wealth Strategies Group, LLC | 8,441 | $44.6K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 10,129 | $53.5K | 0.00% | −9,270−47.8% | Reduced |
| Advisor Group Holdings, Inc. | 11,660 | $61.6K | 0.00% | +1,194+11.4% | Added |
| ExodusPoint Capital Management, LP | 18,443 | $97.0K | 0.00% | +18,443 | New |
| American Century Companies Inc | 20,331 | $107.3K | 0.00% | +20,331 | New |
| Morgan Stanley | 21,459 | $113.3K | 0.00% | +1,885+9.6% | Added |
| Barclays PLC | 23,077 | $121.8K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 23,302 | $123.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 32,291 | $169.0K | 0.00% | +32,291 | New |
| Citigroup Inc | 34,906 | $184.3K | 0.00% | −23,471−40.2% | Reduced |
| Millennium Management LLC | 36,498 | $192.7K | 0.00% | +36,498 | New |
| Northern Trust Corp | 50,018 | $264.1K | 0.00% | +1,179+2.4% | Added |
| Blair William & Co | 68,466 | $361.5K | 0.00% | −19,580−22.2% | Reduced |
| AdvisorShares Investments LLC | 72,071 | $380.5K | 0.06% | +17,760+32.7% | Added |
| State Street Corp | 83,708 | $442.0K | 0.00% | +34,200+69.1% | Added |
| ADAR1 Capital Management, LLC | 89,938 | $474.9K | 0.13% | −155,564−63.4% | Reduced |
| Renaissance Technologies LLC | 109,800 | $580.0K | 0.00% | +109,800 | New |
| Two Sigma Investments, LP | 144,386 | $762.4K | 0.00% | −47,673−24.8% | Reduced |
| BML Capital Management, LLC | 150,000 | $792.0K | 0.53% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 166,164 | $877.3K | 0.00% | +2,376+1.5% | Added |
| Geode Capital Management, LLC | 279,482 | $1.48M | 0.00% | +5,010+1.8% | Added |
| Susquehanna International Group, LLP | 288,885 | $1.53M | 0.00% | +288,885 | New |
| BlackRock Inc. | 348,438 | $1.84M | 0.00% | +1,755+0.5% | Added |
| Armistice Capital, LLC | 364,000 | $1.92M | 0.05% | −114,000−23.8% | Reduced |
| Citadel Advisors LLC | 743,920 | $3.93M | 0.00% | +425+0.1% | Added |
| Sphera Funds Management Ltd. | 808,550 | $4.27M | 0.69% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,517,696 | $8.01M | 0.79% | −299,034−16.5% | Reduced |
| Commodore Capital LP | 1,575,000 | $8.32M | 0.56% | 00.0% | Unchanged |
| StemPoint Capital LP | 1,848,582 | $9.29M | 2.48% | +58,400+3.3% | Added |
| Vanguard Group Inc | 1,793,166 | $9.47M | 0.00% | −41,346−2.3% | Reduced |
| Great Point Partners LLC | 1,858,735 | $9.81M | 1.53% | 00.0% | Unchanged |
| BVF Inc | 2,000,000 | $10.6M | 0.29% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 2,676,580 | $14.1M | 1.12% | 00.0% | Unchanged |
| Bank of Montreal | 0 | $0 | 0.00% | −96,900−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −41,886−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −21,940−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,524−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −15,171−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −12,371−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,437−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −333−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −88−100.0% | Sold out |